Uncovering Institutional Buying In Amicus Therapeutics Inc (NASDAQ: FOLD)
Currently, there are 293.25M common shares owned by the public and among those 284.30M shares have been available to trade. Insiders at the company have transacted a total of 71 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, […]
Set Your Sights On Amicus Therapeutics Inc (NASDAQ: FOLD)’S Upside Potential
Perceptive Advisors LLC has recently announced that it has increased stake in Amicus Therapeutics Inc (NASDAQ:FOLD) by 0.11%. After grabbing 27.69 million shares, the institutional investor is now in possession of 30000.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.44% having worth around $305.18 million. Moreover, The […]
Amicus Therapeutics Inc (FOLD): Not A Time To Panic Nor Freeze
Perceptive Advisors LLC has recently announced that it has increased stake in Amicus Therapeutics Inc (NASDAQ:FOLD) by 0.11%. After grabbing 27.69 million shares, the institutional investor is now in possession of 30000.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.44% having worth around $305.18 million. Moreover, The […]
Amicus Therapeutics Inc (NASDAQ: FOLD) Hogging The Spotlight Today
Perceptive Advisors LLC recently announced the acquisition of new stake in Amicus Therapeutics Inc (NASDAQ:FOLD). The institutional investor has increased its shareholding in the Healthcare company by 0.11% to 27.69 million shares with purchase of 30000.0 shares. This fresh investment now brings its stake to 9.44% valued currently at $305.18 million. In addition, The Vanguard […]